Pete Pharma and Atrium24 partner to expand pharmaceutical 3D printing in independent pharmacies. Explore what this shift means for drug manufacturing.
CereVasc’s eShunt system shows three-year outcomes in idiopathic intracranial hypertension. Discover what this means for future brain pressure treatments.
CordenPharma Colorado expands peptide development capacity with a new Boulder lab facility. Discover what this means for peptide drug manufacturing.
FDA clears Vasomune Therapeutics’ IND for pegevongitide in severe burn resuscitation. Explore what this Tie2 therapy could change for vascular leak treatment.
Airiver Medical wins FDA Breakthrough Device status for its pulmonary drug coated balloon. Discover what this means for airway stenosis treatment and clinical trials.
Can LYMPHIR boost CAR-T therapy success in lymphoma? Discover what early trial data reveals about immune microenvironment targeting.
Azenta acquires UK Biocentre for £20.5M to expand European biorepository capabilities. Discover what this means for life sciences research infrastructure.
Intrinsic Therapeutics launches the Barricaid Narrow Anchor for lumbar discectomy patients. Explore what the smaller implant could change in spine surgery.
Akeso and INOVIO test cadonilimab plus INO-5412 in the INSIGhT glioblastoma trial. Explore what this immunotherapy strategy could mean for GBM research.
Forma Life Sciences launches a U.S. CDMO focused on oral solid drug manufacturing. Discover what the move means for pharma supply chains and drug development.